Publications
Download CSV
Download XLSX
Download TXT
Tables
2026 (58)
2025 (697)
2024 (743)
2023 (750)
2022 (797)
2021 (829)
2020 (649)
2019 (542)
2018 (803)
2017 (914)
2016 (860)
2015 (649)
2014 (589)
2013 (461)
2012 (331)
2011 (191)
2010 (70)
2009 (38)
2008 (39)
2007 (13)
2006 (19)
2005 (9)
2004 (3)
2003 (2)
2002 (1)
All (10057)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
Nilvebrant J
JSON
CSV
XLSX
TXT
Family name
Nilvebrant
Given name
Johan
Initials
J
ORCID
ORCID
0000-0002-6104-6446
Affiliations
Division of Protein Technology, School of Biotechnology, Royal Institute of Technology (KTH), Stockholm, Sweden.
3 publications
PubMed
DOI
Crossref
Progress and Future Directions with Peptide-Drug Conjugates for Targeted Cancer Therapy.
Lindberg J,
Nilvebrant J
,
Nygren PÅ
,
Lehmann F
Molecules
26
(19) - [2021-10-05; online 2021-10-05]
PubMed
DOI
Crossref
Successive crystal structure snapshots suggest the basis for MHC class I peptide loading and editing by tapasin.
Hafstrand I
, Sayitoglu EC,
Apavaloaei A
, ..., Duru AD, Achour A
Proc. Natl. Acad. Sci. U.S.A.
116
(11) 5055-5060 [2019-03-12; online 2019-02-26]
PubMed
DOI
Crossref
Pneumolysin binds to the mannose receptor C type 1 (MRC-1) leading to anti-inflammatory responses and enhanced pneumococcal survival.
Subramanian K
,
Neill DR
, Malak HA, ...,
Kadioglu A
,
Henriques-Normark B
Nat. Microbiol
4
(1) 62-70 [2019-01-00; online 2018-11-12]
SciLifeLab Data Centre
Publications
9.5.1